Annabelle Gariboldi

Annabelle Gariboldi is an experienced Quality Control Engineer at Cellectis since December 2014, specializing in validation, optimization, and development of methods for T Cell CAR engineering aimed at adoptive immunotherapy for cancer. Key projects include the UCART CS1 initiative targeting multiple myeloma in collaboration with Pfizer. Prior to this role, Annabelle worked as an Assistant Engineer at Cellectis Bioresearch from March 2010 to December 2014, focusing on targeted modification of cell lines and project management. Annabelle began a laboratory technician career at BioRep S.r.l. from August 2005 to March 2010, contributing to the establishment of lymphocyte cell lines for European research projects while adhering to ISO 9001:2008 standards. Annabelle holds a Master's degree in Sciences, Technologies, and Health from Paris-Sud University and studied at Università degli Studi di Milano.